M&T Bank Corp purchased a new stake in Iqvia Holdings Inc (NYSE:IQV) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 40,188 shares of the medical research company’s stock, valued at approximately $3,935,000.
Other hedge funds also recently made changes to their positions in the company. Winslow Evans & Crocker Inc. bought a new stake in shares of Iqvia in the 4th quarter valued at about $123,000. IFP Advisors Inc bought a new stake in Iqvia during the 4th quarter worth approximately $200,000. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in Iqvia during the 4th quarter worth approximately $209,000. Atria Investments LLC bought a new stake in Iqvia during the 4th quarter worth approximately $218,000. Finally, First Quadrant L P CA bought a new stake in Iqvia during the 4th quarter worth approximately $221,000. 95.91% of the stock is owned by institutional investors.
IQV has been the subject of a number of research reports. KeyCorp reissued a “sector weight” rating and set a $100.00 target price on shares of Iqvia in a research note on Friday, November 10th. Zacks Investment Research raised Iqvia from a “hold” rating to a “buy” rating and set a $112.00 target price for the company in a research note on Thursday, January 18th. Mizuho cut Iqvia from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a research note on Thursday, November 9th. SunTrust Banks reissued a “hold” rating and set a $110.00 target price on shares of Iqvia in a research note on Monday, January 22nd. Finally, TheStreet raised Iqvia from a “c+” rating to a “b” rating in a research note on Wednesday, December 13th. Seven research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $109.71.
Iqvia (NYSE:IQV) last released its quarterly earnings results on Wednesday, February 14th. The medical research company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.06. Iqvia had a return on equity of 12.60% and a net margin of 0.58%. The firm had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter in the prior year, the firm posted $1.09 EPS. The business’s revenue was up 10.7% on a year-over-year basis. sell-side analysts expect that Iqvia Holdings Inc will post 4.62 earnings per share for the current year.
In other Iqvia news, insider James H. Erlinger III sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 17th. The stock was sold at an average price of $99.97, for a total transaction of $999,700.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $102.00, for a total value of $764,776,314.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,727,078 shares of company stock valued at $890,124,079. Insiders own 6.40% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “40,188 Shares in Iqvia Holdings Inc (IQV) Purchased by M&T Bank Corp” was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://weekherald.com/2018/02/15/40188-shares-in-iqvia-holdings-inc-iqv-purchased-by-mt-bank-corp.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.